MedPath

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON logo
🇺🇸United States
Ownership
Private
Established
1861-01-01
Employees
10K
Market Cap
-
Website
https://www.cs.washington.edu

Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children

Active, not recruiting
Conditions
Obesity, Childhood
First Posted Date
2020-02-07
Last Posted Date
2024-12-11
Lead Sponsor
University of Washington
Target Recruit Count
102
Registration Number
NCT04260048
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

University of Washington, Seattle, Washington, United States

Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma

Phase 1
Recruiting
Conditions
Primary Mediastinal (Thymic) Large B-Cell Lymphoma
B-Cell Non-Hodgkin Lymphoma
Grade 3a Follicular Lymphoma
Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
High Grade B-Cell Lymphoma
Grade 1 Follicular Lymphoma
Grade 2 Follicular Lymphoma
Interventions
First Posted Date
2020-02-06
Last Posted Date
2024-10-29
Lead Sponsor
University of Washington
Target Recruit Count
50
Registration Number
NCT04257578
Locations
🇺🇸

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Telehealth Pain Self-Management for Employed Adults

Not Applicable
Completed
Conditions
Multiple Sclerosis
Brain Injuries, Traumatic
Amputation
Chronic Pain
Spinal Cord Injuries
Interventions
Behavioral: E-TIPS
First Posted Date
2020-01-30
Last Posted Date
2024-07-08
Lead Sponsor
University of Washington
Target Recruit Count
202
Registration Number
NCT04248725
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

The Use of Mentoring to Promote Well-being for Female SMART Members

Not Applicable
Active, not recruiting
Conditions
Harassment, Sexual
Bullying, Workplace
Work-Related Condition
Work-related Injury
Mental Stress
Work Related Stress
Harassment, Non-Sexual
Interventions
Behavioral: Mentoring program
First Posted Date
2020-01-30
Last Posted Date
2023-11-28
Lead Sponsor
University of Washington
Target Recruit Count
230
Registration Number
NCT04247880
Locations
🇺🇸

Sheet Metal Workers Local 85, Atlanta, Georgia, United States

🇺🇸

Columbus Sheet Metal Workers Apprenticeship, Columbus, Ohio, United States

🇺🇸

Sheet Metal Workers Local 19, Philadelphia, Pennsylvania, United States

and more 16 locations

Water-friendly Virtual Reality and Brief Thermal Pain

Not Applicable
Completed
Conditions
Pain, Acute
Interventions
Behavioral: Virtual Reality psychological pain reduction
First Posted Date
2020-01-29
Last Posted Date
2021-10-26
Lead Sponsor
University of Washington
Target Recruit Count
92
Registration Number
NCT04245475
Locations
🇺🇸

University of Washington (public not eligible for participation), Seattle, Washington, United States

Evaluation of Modified Bite-Block for Invasive Imaging Procedures

Not Applicable
Completed
Conditions
Bite Block
Interventions
Device: bite block
First Posted Date
2020-01-22
Last Posted Date
2022-04-15
Lead Sponsor
University of Washington
Target Recruit Count
50
Registration Number
NCT04236297
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

Intradermal, Fractional Dose of HPV Vaccines:

Phase 4
Active, not recruiting
Conditions
HPV Infection
HPV Vaccine
Interventions
Biological: HPV vaccine
First Posted Date
2020-01-21
Last Posted Date
2024-05-14
Lead Sponsor
University of Washington
Target Recruit Count
40
Registration Number
NCT04235257
Locations
🇺🇸

University of Washington Virology Research Clinic, Seattle, Washington, United States

A Multi-Level Approach to Heat-Related Illness Prevention in Agricultural Workers

Not Applicable
Completed
Conditions
Heat Stress Disorders
Interventions
Other: Heat Education and Awareness Tools
First Posted Date
2020-01-21
Last Posted Date
2022-05-17
Lead Sponsor
University of Washington
Target Recruit Count
86
Registration Number
NCT04234802
Locations
🇺🇸

Farms (confidential), Yakima, Washington, United States

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Phase 1
Recruiting
Conditions
Aggressive Non-Hodgkin Lymphoma
ALK-Positive Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
High Grade B-Cell Lymphoma, Not Otherwise Specified
Primary Mediastinal Large B-Cell Lymphoma
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Gray-Zone Lymphoma
Interventions
Drug: Polatuzumab Vedotin
Biological: Rituximab
Drug: Prednisone
Drug: Etoposide
Drug: Doxorubicin
Drug: Cyclophosphamide
Procedure: Multigated Acquisition Scan
Biological: Glofitamab
Procedure: Echocardiography
Procedure: FDG-Positron Emission Tomography
Procedure: Computed Tomography
Procedure: Bone Marrow Biopsy
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
First Posted Date
2020-01-18
Last Posted Date
2024-09-30
Lead Sponsor
University of Washington
Target Recruit Count
56
Registration Number
NCT04231877
Locations
🇺🇸

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

Phase 1
Terminated
Conditions
Sarcoma of the Extremity
Stage I Soft Tissue Sarcoma of the Trunk and Extremities
Stage IB Soft Tissue Sarcoma of the Trunk and Extremities
Stage II Soft Tissue Sarcoma of the Trunk and Extremities
Stage IA Soft Tissue Sarcoma of the Trunk and Extremities
Interventions
Drug: Cabozantinib S-malate
Radiation: Radiation Therapy
First Posted Date
2020-01-07
Last Posted Date
2024-12-02
Lead Sponsor
University of Washington
Target Recruit Count
6
Registration Number
NCT04220229
Locations
🇺🇸

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath